Tag Archives: Beth Dunning

Nanotechnology Policy and Regulation in Canada, Australia, the European Union, the UK, and the US: a timeline for us all

The Timeline: Nanotechnology Policy and Regulation in Canada, Australia, the European Union, the United Kingdom, and the United States (PDF; h/t July 10, 2014 news item on Nanowerk) issued by the University of Ottawa’s Institute for Science, Society and Policy (ISSP) takes as its starting point the invention of the field emission microscope in 1936 by Erwin Wilhelm Müller.

This fascinating 40 pp document seems comprehensive to me. While the title suggests otherwise, there are a few mentions of events involving Asian countries and they also include the Berkeley bylaw governing nanotechnology manufacture in the city. From the Timeline, p. 16 (Note: The formatting has been changed significantly),

The City of Berkeley (US)
December 2006

The Berkeley Municipal Code is amended to introduce new measures regarding manufactured nanomaterial health and safety

These amendments require facilities that manufacture or use nanomaterials to disclose in writing which nanomaterials are being used as well as the current toxicology of the materials reported (to the extent known) and to further describe how the facility will safely handle, monitor, contain, dispose, track inventory, prevent releases and mitigate such materials.

Berkeley is currently the only municipal government in the United States to regulate nanotechnology

While searching a month ago (June 2014), I was having difficulty finding information online about the Berkeley bylaw, so this was a delightful surprise.

There is (arguably) an omission and that is the Yale Law School Cultural Cognition Project. The Yale researchers have done some influential work about emerging technologies, including a special nanotechnology project devised in the aftermath of the Berkeley bylaw. Their focus then and now has been on public perceptions and attitudes as they affect policy.

Given how many public perception projects there have been and the timeline’s specific focus on regulation and policy, it’s understandable that not many have been included in the timeline.

Still, I was curious to see if the 2012 nanosunscreen debacle in Australia would be included in the timeline. It was not and, given that this incident didn’t directly involve policy or regulation, it’s understandable. Still, I would like to suggest its inclusion in future iterations. (For the curious, my Feb. 9, 2012 posting titled: Unintended consequences: Australians not using sunscreens to avoid nanoparticles? offers a summary and links to this story about an Australian government survey and some unexpected and dismaying results.)

The timeline appears to have a publication date of April 2014 and was compiled by Alin Charrière and Beth Dunning. It is a ‘living’ document so it will be updated in the future. If you have any comments, issp@uottawa.ca. (I will be sending mine soon.)

It is one of a series which includes two other technologies, Synthetic biology and Bioenergy, at this point (July 10, 2014). You can go here for more about the ISSP.

Finally, bravo and bravo to Charrière and Dunning for a job well done.

Nanotechnology Policy and Regulation Timeline for Canada, US, Australia, UK, and Europe

Thank you Andrew Maynard (2020 Science blog) for pointing me to this new living document published by the Regulatory Governance Initiative (RGI) at Carleton University. Properly titled as ‘Nanotechnology Policy and Regulation in Canada, Australia, the European Union, the United Kingdom, and the United States’, the document’s chief researcher is Beth Dunning with Marc Saner as the Series Editor. (The group publishes other documents as well.)

The document provides a timeline for significant nanotechnology milestones such as the inception of the US National Nanotechnology Initiative and the 2004 report by Britain’s Royal Society as well as policy and regulation efforts. It is a designated ‘living’ document as the research team is inviting additions and changes to be submitted by email.

The RGI team has not yet included Health Canada’s ‘public consultation’ on their nanomaterials definition. I will contact them about the team at their email address (info@regulatorygovernance.ca <info@regulatorygovernance.ca>) or maybe you’ll beat me to it. You can read more Health Canada’s consultation on my blog here.